nifekalant hydrochloride has been researched along with Tachyarrhythmia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajiki, K; Hayami, N; Kanamori, K; Kunishima, T; Mikamo, T; Murakawa, Y; Sugiura, A; Tsutsui, K; Watanabe, H; Yamagishi, N; Yamagishi, S | 1 |
| Centurion, OA; Hayano, M; Hirata, T; Isomoto, S; Kaibara, M; Konoe, A; Yano, K | 1 |
| Daikoku, S; Kamakura, S; Kurita, T; Miyazaki, S; Morii, I; Nonogi, H; Sutani, Y; Takenaka, K; Yasuda, S | 1 |
| Fuda, Y; Hagiwara, N; Haruta, S; Kasanuki, H; Matsuda, N; Shiga, T | 1 |
| Ishii, M; Kamiya, J; Katakami, T | 1 |
5 other study(ies) available for nifekalant hydrochloride and Tachyarrhythmia
| Article | Year |
|---|---|
Dexmedetomidine and clonidine inhibit ventricular tachyarrhythmias in a rabbit model of acquired long QT syndrome.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Clonidine; Dexmedetomidine; Disease Models, Animal; Heart Conduction System; Humans; Long QT Syndrome; Methoxamine; Pyrimidinones; Rabbits; Tachycardia | 2012 |
Electrophysiological effects of MS-551 in humans: a class III antiarrhythmic agent.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Blood Pressure; Bundle of His; Electrocardiography; Electrophysiology; Female; Heart Atria; Heart Rate; Heart Ventricles; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Pyrimidinones; Refractory Period, Electrophysiological; Sinoatrial Node; Tachycardia | 1995 |
Initial experience with nifekalant hydrochloride (MS-551), a novel class III antiarrhythmic agent, in patients with acute extensive infarction and severe ventricular dysfunction.
Topics: Aged; Anti-Arrhythmia Agents; Electrocardiography; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Potassium Channel Blockers; Pyrimidinones; Tachycardia; Ventricular Dysfunction | 2001 |
Antiarrhythmic effect of nifekalant on atrial tachyarrhythmia in four patients with severe heart failure.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrimidinones; Tachycardia | 2002 |
Antiarrhythmic effects of MS-551, a new class III antiarrhythmic agent, on canine models of ventricular arrhythmia.
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Digitalis Glycosides; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Female; Heart Rate; Injections, Intravenous; Male; Pyrimidinones; Tachycardia | 1992 |